Palisade Bio (PALI) Accumulated Depreciation & Amortization (2016 - 2020)
Palisade Bio (PALI) has disclosed Accumulated Depreciation & Amortization for 10 consecutive years, with $910956.0 as the latest value for Q4 2020.
- On a quarterly basis, Accumulated Depreciation & Amortization fell 4.15% to $910956.0 in Q4 2020 year-over-year; TTM through Dec 2020 was $910956.0, a 4.15% decrease, with the full-year FY2020 number at $910956.0, down 4.15% from a year prior.
- Accumulated Depreciation & Amortization was $910956.0 for Q4 2020 at Palisade Bio, down from $950417.0 in the prior quarter.
- In the past five years, Accumulated Depreciation & Amortization ranged from a high of $950417.0 in Q4 2019 to a low of $724771.0 in Q4 2016.
- A 5-year average of $862065.8 and a median of $902260.0 in 2018 define the central range for Accumulated Depreciation & Amortization.
- Peak YoY movement for Accumulated Depreciation & Amortization: rose 15.31% in 2016, then decreased 4.15% in 2020.
- Palisade Bio's Accumulated Depreciation & Amortization stood at $724771.0 in 2016, then increased by 13.4% to $821925.0 in 2017, then grew by 9.77% to $902260.0 in 2018, then grew by 5.34% to $950417.0 in 2019, then fell by 4.15% to $910956.0 in 2020.
- Per Business Quant, the three most recent readings for PALI's Accumulated Depreciation & Amortization are $910956.0 (Q4 2020), $950417.0 (Q4 2019), and $902260.0 (Q4 2018).